Peter Sleight
- Beta blockade during and after myocardial infarction: An overview of the randomized trials
1985/03/01 by Salim Yusuf, Richard Peto, John Lewis +3 · 22 citations
Economics, Econometrics and Finance · Medicine · #Heart Failure Treatment and Management #Medication Adherence and Compliance #Pharmaceutical Economics and Policy
- 2013 ESH/ESC Guidelines for the management of arterial hypertension
2013/06/14 by Giuseppe Mancia, Josep Redón, Alberto Zanchetti +84 · 11 citations
Medicine · Economics, Econometrics and Finance · #Blood Pressure and Hypertension Studies #Cardiac, Anesthesia and Surgical Outcomes #Health Systems, Economic Evaluations, Quality of Life
- Benefits, challenges, and registerability of the polypill
2006/01/25 by Peter Sleight · 2 citations
Medicine · Economics, Econometrics and Finance · Health Professions · #Medication Adherence and Compliance #Pharmaceutical Economics and Policy #Mobile Health and mHealth Applications
- Angiotensin II and trials of cardiovascular outcomes11Reprints are not available.
2002/01/01 by Peter Sleight · 8 citations
Medicine · #ACE inhibitor #Angiotensin II #Angiotensin-converting enzyme #Blood Pressure and Hypertension Studies #Blood pressure #Captopril #Cardiology #Enalapril #Heart Failure Treatment and Management #Heart failure #Hormonal Regulation and Hypertension #Hypertensive heart disease #Internal medicine #Medicine #Myocardial infarction #Ramipril #Trandolapril